Genetic Pulmonary Disorders for EMS Personnel

At the completion of this continuing education course, EMS personnel will be able to:

1. Identify the genetic and physiological mechanisms underlying common hereditary pulmonary disorders such as cystic fibrosis, alpha-1 antitrypsin deficiency, and primary ciliary dyskinesia.

2. Differentiate between the clinical presentations of pediatric and adult patients with genetic pulmonary diseases during acute respiratory events.

3. Apply appropriate prehospital interventions for managing respiratory emergencies associated with specific genetic lung disorders.

4. Analyze the impact of emerging diagnostic tools and targeted treatments (e.g., CFTR modulators, gene therapy) on EMS decision-making and patient outcomes.

5. Evaluate airway management strategies and transport considerations tailored to patients with rare or complex genetic pulmonary conditions.

Genetic disorders of the pulmonary system are increasingly recognized as critical contributors to respiratory emergencies encountered in the prehospital setting. With advances in diagnostics and treatment, patients with conditions such as cystic fibrosis, alpha-1 antitrypsin deficiency, and primary ciliary dyskinesia are living longer and presenting with complex respiratory profiles across the lifespan. Emergency medical services personnel must be equipped with specialized knowledge to rapidly assess, stabilize, and manage acute complications associated with these disorders. A strong understanding of genetic pathophysiology, disease progression, and individualized patient needs enhances clinical decision-making and improves outcomes during time-sensitive interventions. This course bridges foundational science with practical EMS application, preparing providers to respond with confidence to rare but increasingly encountered respiratory conditions.